Literature DB >> 21645254

Transmission of human immunodeficiency virus and hepatitis C virus from an organ donor to four transplant recipients.

M G Ison1, E Llata, C S Conover, J J Friedewald, S I Gerber, A Grigoryan, W Heneine, J M Millis, D M Simon, C-G Teo, M J Kuehnert.   

Abstract

In 2007, a previously uninfected kidney transplant recipient tested positive for human immunodeficiency virus type 1 (HIV) and hepatitis C virus (HCV) infection. Clinical information of the organ donor and the recipients was collected by medical record review. Sera from recipients and donor were tested for serologic and nucleic acid-based markers of HIV and HCV infection, and isolates were compared for genetic relatedness. Routine donor serologic screening for HIV and HCV infection was negative; the donor's only known risk factor for HIV was having sex with another man. Four organs (two kidneys, liver and heart) were transplanted to four recipients. Nucleic acid testing (NAT) of donor sera and posttransplant sera from all recipients were positive for HIV and HCV. HIV nucleotide sequences were indistinguishable between the donor and four recipients, and HCV subgenomic sequences clustered closely together. Two patients subsequently died and the transplanted organs failed in the other two patients. This is the first recognized cotransmission of HIV and HCV from an organ donor to transplant recipients. Routine posttransplant HIV and HCV serological testing and NAT of recipients of organs from donors with suspected risk factors should be considered as routine practice. ©2011 The Authors Journal compilation©2011 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Mesh:

Year:  2011        PMID: 21645254     DOI: 10.1111/j.1600-6143.2011.03597.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  20 in total

1.  Validation of Virus NAT for HIV, HCV, HBV and HAV Using Post-Mortal Blood Samples.

Authors:  Knut Gubbe; Yvonne Scharnagl; Steffi Grosch; Torsten Tonn; Michael Schmidt; Kai M Hourfar; Andreas Karl; Erhard Seifried; Ina Wilkemeyer; Ulrich Kalus
Journal:  Transfus Med Hemother       Date:  2012-11-13       Impact factor: 3.747

2.  PHS guideline for reducing human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission through organ transplantation.

Authors:  Debbie L Seem; Ingi Lee; Craig A Umscheid; Matthew J Kuehnert
Journal:  Public Health Rep       Date:  2013-07       Impact factor: 2.792

3.  Guidelines for the assessment and acceptance of potential brain-dead organ donors.

Authors:  Glauco Adrieno Westphal; Valter Duro Garcia; Rafael Lisboa de Souza; Cristiano Augusto Franke; Kalinca Daberkow Vieira; Viviane Renata Zaclikevis Birckholz; Miriam Cristine Machado; Eliana Régia Barbosa de Almeida; Fernando Osni Machado; Luiz Antônio da Costa Sardinha; Raquel Wanzuita; Carlos Eduardo Soares Silvado; Gerson Costa; Vera Braatz; Milton Caldeira Filho; Rodrigo Furtado; Luana Alves Tannous; André Gustavo Neves de Albuquerque; Edson Abdala
Journal:  Rev Bras Ter Intensiva       Date:  2016-09

4.  Organs from deceased donors with false-positive HIV screening tests: An unexpected benefit of the HOPE act.

Authors:  Christine M Durand; Samantha E Halpern; Mary G Bowring; Gilad A Bismut; Oyinkansola T Kusemiju; Brianna Doby; Reinaldo E Fernandez; Charles S Kirby; Darin Ostrander; Peter G Stock; Shikha Mehta; Nicole A Turgeon; David Wojciechowski; Shirish Huprikar; Sander Florman; Shane Ottmann; Niraj M Desai; Andrew Cameron; Allan B Massie; Aaron A R Tobian; Andrew D Redd; Dorry L Segev
Journal:  Am J Transplant       Date:  2018-07-23       Impact factor: 8.086

5.  KDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors.

Authors:  Krista L Lentine; Bertram L Kasiske; Andrew S Levey; Patricia L Adams; Josefina Alberú; Mohamed A Bakr; Lorenzo Gallon; Catherine A Garvey; Sandeep Guleria; Philip Kam-Tao Li; Dorry L Segev; Sandra J Taler; Kazunari Tanabe; Linda Wright; Martin G Zeier; Michael Cheung; Amit X Garg
Journal:  Transplantation       Date:  2017-08       Impact factor: 4.939

6.  Donor-derived infection: epidemiology and outcomes.

Authors:  Daniel R Kaul
Journal:  Curr Infect Dis Rep       Date:  2012-12       Impact factor: 3.725

Review 7.  Selecting suitable solid organ transplant donors: Reducing the risk of donor-transmitted infections.

Authors:  Christopher S Kovacs; Christine E Koval; David van Duin; Amanda Guedes de Morais; Blanca E Gonzalez; Robin K Avery; Steven D Mawhorter; Kyle D Brizendine; Eric D Cober; Cyndee Miranda; Rabin K Shrestha; Lucileia Teixeira; Sherif B Mossad
Journal:  World J Transplant       Date:  2014-06-24

Review 8.  Expanded criteria donors.

Authors:  Sandy Feng; Jennifer C Lai
Journal:  Clin Liver Dis       Date:  2014-08       Impact factor: 6.126

9.  Guidance on the use of increased infectious risk donors for organ transplantation.

Authors: 
Journal:  Transplantation       Date:  2014-08-27       Impact factor: 4.939

Review 10.  Multidrug-Resistant Bacterial Donor-Derived Infections in Solid Organ Transplantation.

Authors:  Jessica D Lewis; Costi D Sifri
Journal:  Curr Infect Dis Rep       Date:  2016-06       Impact factor: 3.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.